Biopreservation Market Growth, Trends, and Forecast to 2029: Accelerating Biobanking, Cell Therapy, and Personalized Med

Prominent companies in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), and Azenta, Inc. (US).

The global biopreservation market is witnessing significant growth as the demand for advanced storage solutions for biological materials continues to rise. Increasing investments in biobanking, regenerative medicine, cell and gene therapy, and personalized healthcare are driving the adoption of innovative biopreservation technologies worldwide.

The global biopreservation market was valued at US$3.7 billion in 2022, reached approximately US$4.4 billion in 2024, and is projected to grow at a strong CAGR of 9.8% from 2024 to 2029, reaching around US$7.1 billion by 2029.

This expansion is driven by the increasing need to preserve biological samples, growing healthcare expenditure, rising demand for precision medicine, and advancements in biobank infrastructure. However, challenges such as high costs associated with advanced preservation techniques and stability concerns related to cryopreservation may impact market growth.

Biopreservation plays a critical role in maintaining the quality, functionality, and viability of biological materials such as tissues, cells, organs, and genetic samples. These preservation solutions are essential for research, diagnostics, therapeutic development, and clinical applications.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=842

Rising Importance of Biopreservation in Modern Healthcare

Biopreservation refers to the storage and maintenance of biological samples under controlled conditions to prevent degradation and preserve their biological properties.

High-quality preservation techniques are increasingly important in areas such as:

  • Stem cell research
  • Regenerative medicine
  • Organ transplantation
  • Drug discovery
  • Genomic studies
  • Personalized medicine

As biomedical research becomes more dependent on biological samples, the need for reliable preservation systems continues to increase.

The growing adoption of biobanks has further strengthened demand for advanced preservation solutions. Biobanks collect and store biological specimens that support research programs, disease studies, and development of targeted therapies.

Additionally, increasing interest in newborn cord blood preservation and stem cell storage is contributing to market expansion.

Key Factors Driving the Biopreservation Market Growth

One of the primary drivers of the biopreservation market is the growing investment in healthcare and life sciences research. Governments, academic institutions, and biotechnology companies are increasing funding for biomedical studies, creating demand for advanced sample preservation technologies.

The rising prevalence of chronic diseases has also increased the need for innovative treatments and research approaches. Biological samples preserved through advanced technologies support the discovery of new therapies and improve understanding of disease mechanisms.

Another major growth factor is the increasing adoption of personalized medicine. Precision healthcare relies on detailed biological information from patient samples, making effective preservation techniques essential for maintaining sample quality.

The expansion of cell and gene therapy research is also creating new opportunities, as these therapies require highly controlled storage and transportation conditions.

Biopreservation Media Segment Leading Product Category

Based on product type, the biopreservation market is segmented into:

  • Biopreservation media
  • Biopreservation equipment
  • Biopreservation accessories

The biopreservation media segment accounted for the largest market share due to its frequent use in laboratories and research facilities.

Biopreservation media plays a crucial role in maintaining sample stability during storage and transportation. Compared with equipment and accessories, media products are purchased more frequently, contributing to their strong market position.

These solutions help protect biological samples by providing optimal environments that support cell viability and prevent damage during preservation.

Meanwhile, the biopreservation equipment segment is expected to experience significant growth due to increasing demand for advanced freezers, storage systems, and automated preservation platforms.

Human Tissue Samples Dominating Biospecimen Segment

Based on biospecimen type, the biopreservation market is categorized into:

  • Human tissue samples
  • Organs
  • Stem cells
  • Other biospecimens

The human tissue samples segment held the largest market share due to increasing demand from biomedical research and clinical studies.

Human tissue samples are essential for applications such as:

  • Cancer research
  • Genomics
  • Proteomics
  • Drug development
  • Disease modeling

The growth of translational research and precision medicine has increased the requirement for high-quality preserved tissue samples.

Researchers depend on reliable biopreservation systems to maintain sample integrity and ensure accurate experimental results.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=842

Research Applications Driving Market Expansion

Based on application, the biopreservation market is segmented into:

  • Therapeutic applications
  • Research applications
  • Other applications

The research applications segment accounted for the largest market share due to increasing scientific activities in areas such as:

  • Stem cell research
  • Regenerative medicine
  • Tissue engineering
  • Drug discovery
  • Genomic studies
  • Organ transplantation research

Biopreservation technologies enable researchers to store biological materials for extended periods while maintaining their usability.

The growing number of biotechnology studies and pharmaceutical research programs is expected to continue supporting demand for preservation solutions.

Opportunities in Cell and Gene Therapy and Organ Transplantation

The expanding field of cell and gene therapy represents a major opportunity for the biopreservation market.

These advanced therapies require precise handling and storage of biological materials throughout manufacturing, transportation, and clinical use.

Biopreservation solutions help ensure:

  • Cell viability
  • Product stability
  • Safe transportation
  • Consistent therapeutic performance

Similarly, increasing demand for organ transplantation is creating the need for improved preservation methods that extend organ viability and improve transplant success rates.

Innovations in cryopreservation, vitrification, and temperature-controlled logistics are expected to open new growth opportunities.

Challenges Limiting Market Growth

Despite strong growth potential, the biopreservation market faces certain challenges.

The high cost of advanced preservation systems remains a major limitation, particularly for smaller research organizations and healthcare facilities. Specialized equipment, monitoring systems, and controlled storage environments require significant investments.

Cryopreservation also presents technical challenges related to sample stability, temperature control, and long-term preservation quality.

Maintaining reliable cold-chain logistics during transportation is another critical challenge, especially for sensitive biological materials.

Companies are focusing on developing cost-effective solutions and improving preservation technologies to overcome these barriers.

North America Leading the Global Biopreservation Market

Geographically, the biopreservation market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC.

North America dominates the global biopreservation market due to advanced healthcare infrastructure, strong biotechnology presence, and high research investments.

Key factors supporting regional growth include:

  • Availability of advanced preservation technologies
  • Strong biobanking networks
  • Increasing government funding
  • Growth of cell and gene therapy research
  • Presence of leading market players

The region continues to invest heavily in biomedical innovation, strengthening its position in the global market.

Meanwhile, the Asia Pacific region is expected to register the fastest growth rate due to expanding healthcare infrastructure, rising biotechnology investments, and increasing research activities.

Competitive Landscape of the Biopreservation Market

The global biopreservation market is highly competitive, with leading companies focusing on innovation, partnerships, and expansion of preservation technologies.

Major players include Thermo Fisher Scientific, Merck KGaA, PHC Holdings Corporation, and Azenta Inc..

Recent industry developments include investments in bioprocessing facilities, next-generation ultra-low temperature freezers, and advanced cold-chain solutions to support growing demand.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=842

Future Outlook of the Biopreservation Market

The future of the biopreservation market is closely linked to advancements in biotechnology, regenerative medicine, and personalized healthcare.

Emerging trends such as automated biobanking, improved cryopreservation methods, digital sample tracking, and advanced storage systems are expected to reshape the industry.

As research organizations and healthcare providers continue to rely on biological samples for innovation, biopreservation will remain a critical foundation for modern medicine.

With increasing demand for cell therapies, organ transplantation, and precision medicine solutions, the biopreservation market is positioned for sustained growth through 2029 and beyond.


Prachi001

48 Blog posting

Komentar